$593 Million is the total value of Rhenman & Partners Asset Management AB's 89 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 36.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SELECT SECTOR SPDR TRput | $31,900,000 | – | 440,000 | +100.0% | 5.38% | – | |
| ALXN | Buy | Alexion Pharmaceuticals Inc | $19,926,000 | +144.8% | 114,978 | +161.3% | 3.36% | +42.4% |
| CELG | Sell | Celgene Corp | $17,407,000 | -14.5% | 151,000 | -17.0% | 2.94% | -50.3% |
| MRK | Buy | Merck & Co Inc | $17,244,000 | +279.6% | 300,000 | +275.0% | 2.91% | +120.8% |
| BIIB | Buy | Biogen Inc | $17,185,000 | +135.5% | 40,700 | +89.3% | 2.90% | +37.0% |
| AMGN | Buy | Amgen Inc | $15,825,000 | +153.6% | 99,000 | +152.8% | 2.67% | +47.6% |
| ALKS | Buy | Alkermes Plc | $15,730,000 | +87.8% | 258,000 | +80.4% | 2.65% | +9.3% |
| GILD | Sell | Gilead Sciences Inc | $15,603,000 | -19.7% | 159,000 | -22.9% | 2.63% | -53.3% |
| UNH | Buy | United Health Group Inc | $15,378,000 | +127.0% | 130,000 | +94.0% | 2.59% | +32.1% |
| CVS | Buy | CVS Health Corp | $14,965,000 | +60.2% | 145,000 | +49.5% | 2.52% | -6.8% |
| B108PS | Buy | Actavis Plc | $13,482,000 | +94.0% | 45,300 | +67.8% | 2.27% | +12.9% |
| ABBV | Buy | AbbVie Inc | $12,879,000 | +40.6% | 220,000 | +57.1% | 2.17% | -18.2% |
| CAH | Buy | Cardinal Health Inc | $12,764,000 | +125.9% | 141,400 | +102.0% | 2.15% | +31.4% |
| ESPR | Sell | Esperion Therapeutics Inc | $11,753,000 | +93.8% | 126,926 | -15.4% | 1.98% | +12.7% |
| RAD | Buy | Rite Aid Corp | $11,092,000 | +87.9% | 1,276,462 | +62.6% | 1.87% | +9.3% |
| INCY | Buy | Incyte Corp Ltd | $10,999,000 | +241.9% | 120,000 | +172.7% | 1.86% | +99.0% |
| NKTR | Buy | Nektar Therapeutics | $10,963,000 | +197.2% | 996,600 | +318.7% | 1.85% | +73.0% |
| UHS | New | Universal Health Services Inc B | $10,241,000 | – | 87,000 | +100.0% | 1.73% | – |
| REGN | Sell | Regeneron Pharmaceuticals Inc | $9,933,000 | +7.6% | 22,000 | -2.2% | 1.68% | -37.4% |
| JAZZ | Buy | Jazz Pharmaceuticals Plc | $9,503,000 | +233.6% | 55,000 | +216.1% | 1.60% | +93.9% |
| LLY | Buy | Eli Lilly & Co | $9,372,000 | +105.8% | 129,000 | +95.5% | 1.58% | +19.7% |
| BMRN | Buy | BioMarin Pharmaceutical Inc | $9,347,000 | +69.5% | 75,000 | +23.0% | 1.58% | -1.4% |
| MDVN | Sell | Medivation Inc | $8,906,000 | +26.5% | 69,000 | -2.4% | 1.50% | -26.4% |
| New | Anthem Inc | $8,801,000 | – | 57,000 | +100.0% | 1.48% | – | |
| MCK | Buy | McKesson Corp | $8,596,000 | +158.8% | 38,000 | +137.5% | 1.45% | +50.5% |
| BMY | Buy | Bristol Myers Squibb Co | $8,321,000 | +22.6% | 129,000 | +12.2% | 1.40% | -28.7% |
| RCPT | Sell | Receptos Inc | $7,173,000 | +11.5% | 43,500 | -17.2% | 1.21% | -35.2% |
| VRX | New | Valeant Pharm Intl Inc | $7,150,000 | – | 36,000 | +100.0% | 1.21% | – |
| CYBX | Buy | Cyberonics Inc | $7,011,000 | +214.8% | 108,000 | +170.0% | 1.18% | +83.3% |
| VRTX | Buy | Vertex Pharmaceuticals Inc | $6,842,000 | +51.6% | 58,000 | +52.6% | 1.15% | -11.8% |
| New | Becton Dickinson & Co | $6,746,000 | – | 46,982 | +100.0% | 1.14% | – | |
| OREX | Buy | Orexigen Therapeutics Inc | $6,513,000 | +186.5% | 831,800 | +121.8% | 1.10% | +66.6% |
| ISIS | Buy | Isis Pharmaceuticals Inc | $6,494,000 | +150.4% | 102,000 | +142.9% | 1.10% | +45.6% |
| ICPT | Buy | Intercept Pharmaceuticals Inc | $6,486,000 | +89.0% | 23,000 | +4.5% | 1.09% | +9.9% |
| CEMP | New | Cempra Inc | $6,358,000 | – | 185,300 | +100.0% | 1.07% | – |
| CYH | Buy | Community Health Syst Inc | $6,169,000 | +78.8% | 118,000 | +84.4% | 1.04% | +4.0% |
| ACAD | Buy | Acadia Pharmaceuticals Inc | $5,573,000 | +6.4% | 171,000 | +3.6% | 0.94% | -38.1% |
| HCA | Buy | HCA Holdings Inc | $5,567,000 | +85.0% | 74,000 | +80.5% | 0.94% | +7.7% |
| ALNY | Buy | Alnylam Pharmaceuticals Inc | $5,534,000 | +148.1% | 53,000 | +130.4% | 0.93% | +44.2% |
| SUPN | Buy | Supernus Pharmaceuticals Inc | $5,450,000 | +161.8% | 450,800 | +79.7% | 0.92% | +52.4% |
| MDT | Buy | Medtronic Plc | $5,381,000 | +112.9% | 69,000 | +97.1% | 0.91% | +23.9% |
| LH | New | Laboratory Corp of America Hgs | $4,918,000 | – | 39,000 | +100.0% | 0.83% | – |
| RVNC | Buy | Revance Therapeutics Inc | $4,892,000 | +128.2% | 236,000 | +86.5% | 0.82% | +32.9% |
| CERN | Buy | Cerner Corp | $4,835,000 | +96.8% | 66,000 | +73.7% | 0.82% | +14.5% |
| DXCM | Buy | Dexcom Inc | $4,800,000 | +36.2% | 77,000 | +20.3% | 0.81% | -20.8% |
| AMSG | Buy | Amsurg Corp | $4,676,000 | +81.8% | 76,000 | +61.7% | 0.79% | +5.8% |
| TTPH | New | Tetraphase Pharmaceuticals Inc | $4,470,000 | – | 122,000 | +100.0% | 0.75% | – |
| AET | Buy | Aetna Inc | $4,368,000 | +75.6% | 41,000 | +46.4% | 0.74% | +2.2% |
| ITCI | Buy | Intra-Cellular Therapies Inc | $4,370,000 | +54.9% | 183,000 | +14.5% | 0.74% | -9.9% |
| ABC | Sell | AmerisourceBergen Corp | $4,319,000 | +19.8% | 38,000 | -5.0% | 0.73% | -30.3% |
| CLVS | Sell | Clovis Oncology Inc | $4,008,000 | -16.2% | 54,000 | -36.8% | 0.68% | -51.2% |
| ABMD | Sell | Abiomed Inc | $3,937,000 | +41.7% | 55,000 | -24.7% | 0.66% | -17.5% |
| OCR | Buy | Omnicare Inc | $3,853,000 | +111.4% | 50,000 | +100.0% | 0.65% | +23.1% |
| KERX | Buy | Keryx Biopharmaceuticals Inc | $3,781,000 | +195.6% | 297,000 | +228.5% | 0.64% | +72.0% |
| THOR | Sell | Thoratec Corp | $3,644,000 | +22.0% | 87,000 | -5.4% | 0.61% | -29.0% |
| RIGL | New | Rigel Pharmaceuticals Inc | $3,570,000 | – | 1,000,000 | +100.0% | 0.60% | – |
| CNC | Buy | Centene Corp | $3,393,000 | +16.7% | 48,000 | +71.4% | 0.57% | -32.1% |
| HOLX | Buy | Hologic Inc | $3,336,000 | +32.7% | 101,000 | +7.4% | 0.56% | -22.9% |
| MGNX | Buy | Macrogenics Inc | $3,325,000 | +26.4% | 106,000 | +41.3% | 0.56% | -26.4% |
| CLDX | Sell | Celldex Therapeutics Inc | $3,317,000 | +3.9% | 119,000 | -32.0% | 0.56% | -39.6% |
| ELGX | Endologix Inc | $3,312,000 | +11.7% | 194,000 | 0.0% | 0.56% | -35.1% | |
| PRGO | New | Perrigo Co Plc | $3,311,000 | – | 20,000 | +100.0% | 0.56% | – |
| STJ | Buy | St Jude Medical Inc | $3,192,000 | +22.7% | 48,800 | +22.0% | 0.54% | -28.6% |
| ARIA | Sell | Ariad Pharmaceuticals Inc | $3,189,000 | +16.9% | 387,000 | -2.5% | 0.54% | -31.9% |
| ANTH | Buy | Anthera Pharmaceuticals Inc | $3,135,000 | +396.0% | 701,314 | +75.3% | 0.53% | +189.1% |
| TEVA | New | Teva Pharma Ind Ltd ADR repr 1 Share | $3,115,000 | – | 50,000 | +100.0% | 0.52% | – |
| TSRO | Sell | Tesaro Inc | $3,042,000 | +30.6% | 52,999 | -15.4% | 0.51% | -24.0% |
| LGND | Ligand Pharmaceuticals Inc B | $3,007,000 | +44.9% | 39,000 | 0.0% | 0.51% | -15.6% | |
| PODD | Buy | Insulet Corp | $3,002,000 | +25.3% | 90,000 | +73.1% | 0.51% | -27.1% |
| CPHD | Cepheid Inc | $2,959,000 | +5.1% | 52,000 | 0.0% | 0.50% | -38.8% | |
| SYK | New | Stryker Corp | $2,952,000 | – | 32,000 | +100.0% | 0.50% | – |
| ARRY | Sell | Array BioPharma Inc | $2,948,000 | +14.4% | 400,000 | -26.6% | 0.50% | -33.5% |
| XNCR | Buy | Xencor Inc | $2,911,000 | +263.0% | 190,000 | +280.0% | 0.49% | +111.6% |
| New | Heartware Intl Inc | $2,896,000 | – | 33,000 | +100.0% | 0.49% | – | |
| OMCL | New | Omnicell Inc | $2,808,000 | – | 80,000 | +100.0% | 0.47% | – |
| ACHN | Sell | Achillion Pharmaceuticals Inc | $2,761,000 | -38.8% | 280,000 | -23.9% | 0.47% | -64.3% |
| DVAX | Dynavax Technologies Corp | $2,755,000 | +33.0% | 122,835 | 0.0% | 0.46% | -22.5% | |
| EW | Edwards Lifesciences Corp | $2,707,000 | +11.9% | 19,000 | 0.0% | 0.46% | -35.0% | |
| TNDM | Buy | Tandem Diabetes Care Inc | $2,638,000 | +16.1% | 209,000 | +16.8% | 0.44% | -32.5% |
| KITE | Buy | Kite Pharma Inc | $2,596,000 | +28.6% | 45,000 | +28.6% | 0.44% | -25.1% |
| ENDP | New | Endo International Plc | $2,399,000 | – | 26,741 | +100.0% | 0.40% | – |
| CLDN | Sell | Celladon Corp | $2,274,000 | -40.6% | 120,053 | -38.7% | 0.38% | -65.5% |
| MYGN | Buy | Myriad Genetics Inc | $2,124,000 | +24.7% | 60,000 | +20.0% | 0.36% | -27.5% |
| AAVL | New | Avalanche Biotechnologies Inc | $1,742,000 | – | 43,000 | +100.0% | 0.29% | – |
| LXRX | Lexicon Pharmaceuticals Inc | $1,506,000 | +3.8% | 1,594,805 | 0.0% | 0.25% | -39.7% | |
| MRTX | New | Mirati Therapeutics Inc | $1,331,000 | – | 45,388 | +100.0% | 0.22% | – |
| THLD | Threshold Pharmaceuticals | $818,000 | +27.6% | 201,537 | 0.0% | 0.14% | -25.8% | |
| BINDQ | BIND Therapeutics Inc | $733,000 | +1.7% | 133,535 | 0.0% | 0.12% | -40.7% | |
| CMRX | New | Chimerix Inc | $535,000 | – | 14,200 | +100.0% | 0.09% | – |
| Exit | Mirati Therapeutics Inc | $0 | – | -45,388 | -100.0% | -0.24% | – | |
| PCYC | Exit | Pharmacyclics Inc | $0 | – | -18,500 | -100.0% | -0.66% | – |
| ORI | Exit | Omnicell Inc | $0 | – | -70,000 | -100.0% | -0.67% | – |
| Exit | Auxilium Pharmaceuticals Inc | $0 | – | -77,000 | -100.0% | -0.77% | – | |
| TMO | Exit | Thermo Fisher Scientific Inc | $0 | – | -22,000 | -100.0% | -0.80% | – |
| HTWR | Exit | Heartware Intl Inc | $0 | – | -38,000 | -100.0% | -0.81% | – |
| BDX | Exit | Becton Dickinson & Co | $0 | – | -20,142 | -100.0% | -0.81% | – |
| P103PS | Exit | NPS Pharmaceuticals Inc | $0 | – | -89,000 | -100.0% | -0.92% | – |
| SLXP | Exit | Salix Pharmaceutical Ltd | $0 | – | -38,000 | -100.0% | -1.27% | – |
| Exit | Catamaran Corp | $0 | – | -92,000 | -100.0% | -1.38% | – | |
| ANTM | Exit | Anthem Inc | $0 | – | -41,000 | -100.0% | -1.49% | – |
| F113PS | Exit | Covidien Plc | $0 | – | -57,000 | -100.0% | -1.69% | – |
| UTI | Exit | Universal Health Services Inc B | $0 | – | -61,000 | -100.0% | -1.97% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.